title: [Contemporary diagnostics and therapy of osteoporosis].
abstract: Since the World Health Organisation's announcement of the "Bone and Joint Decade 2000-2010" diseases of the musculoskeletal system attract more and more attention throughout patients and professional health care providers. In an aging society especially osteoporosis represents a major public health concern. Fragility fractures are the most limiting condition in osteoporosis with the highest impact on both, life quality and health care systems worldwide. Orthopaedic surgeons play a key role in implementing primary diagnostics and therapy in patients with fragility fractures. Objective of this effort is the reduction of the common subsequent fractures in patients with osteoporosis. According to national and international guidelines implementation of contemporary clinical pathways to diagnose and treat patients with fractures due to diminished bone mineral density is fast, simple and proven to be effective.
authors.affiliation: Chirurgische Klinik und Poliklinik der Universität München-Innenstadt, München. tobias.vogel@med.uni-muenchen.de
authors.forename: T
authors.initials: T
authors.lastname: Vogel
authors.forename: H
authors.initials: H
authors.lastname: Bitterling
authors.forename: T
authors.initials: T
authors.lastname: Dobler
authors.forename: R
authors.initials: R
authors.lastname: Bartl
authors.forename: K-J
authors.initials: KJ
authors.lastname: Pfeifer
authors.forename: W
authors.initials: W
authors.lastname: Mutschler
mesh_terms: D015502:Absorptiometry, Photon; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001851:Bone Diseases, Metabolic / Q000175:diagnosis; D002118:Calcium / Q000008:administration & dosage / Q000627:therapeutic use; D002762:Cholecalciferol / Q000008:administration & dosage / Q000627:therapeutic use; D004164:Diphosphonates / Q000008:administration & dosage / Q000627:therapeutic use; D020847:Estrogen Receptor Modulators / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D017410:Practice Guidelines as Topic; D011788:Quality of Life; D012307:Risk Factors; D014944:World Health Organization
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D020847:Estrogen Receptor Modulators; D002762:Cholecalciferol; D002118:Calcium